No abstract

In this work, the adsorption of chemical oxygen demand (COD) and biological oxygen demand (BOD) from treated sewage with low-cost activated carbon prepared from date palm shell waste by chemical activation method was studied. Different parameters affecting the adsorption process such as carbon dose, pH, contact time, agitation rate, and temperature were studied. Adsorption equilibrium was attained after 150 min at pH 6.0 with agitation rate of 400 rpm at 25 °C. The results showed that COD removal percentage of 95.4 and 92.8% for BOD was obtained with carbon dosage of 0.1 g/100 ml of solution. The experimental batch equilibrium results follow linear, Langmuir, and Freundlich isotherm models. The experimental data was fitted to a pseudo-second-order kinetics model controlled by pore diffusion. Thermodynamic parameter values of ΔH , ΔG, and ΔS were calculated. The obtained data indicated that the adsorption was spontaneous, endothermic nature and reflects an increased randomness and degree of disorderliness at the activated carbon/sewage interface during the adsorption process investigated in this study. Concentrations of different impurities were reduced to very small value by investigated adsorption process.

Click chemistry has been utilised for the preparation of new tris(triazolyl)triazines containing aliphatic and polar side chains through coupling of 2,4,6-triethynyl-[1,3,5]triazines, which possess free terminal alkyne moieties with substituted aromatic azides. The cytotoxic activity and in vitro anticancer potential of the newly synthesised compounds have been evaluated against seven human cancer cell lines including liver HepG2, breast MCF-7, lung A549, acute myeloid leukemia HL-60, colon HCT116, and prostate PC3 cancer cell lines in addition to human normal melanocyte, HFB4. The results revealed that all the compounds did not exhibit any activity against A549, HL-60, and PC3. However compound G2 was effective against MCF-7 and HepG2 cancer cell lines. On the other hand, compound G1a exhibited higher potency against MCF-7 and HepG2 cells with no toxicity on normal cells in comparison with the standard drug doxorubicin.

No abstract